Citadel Advisors - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 112 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,204
-91.1%
17,674
-92.7%
0.00%
Q4 2022$24,865
-34.6%
241,407
-2.5%
0.00%
Q3 2022$38,000
-97.1%
247,498
-83.5%
0.00%
Q2 2022$1,320,000
-3.6%
1,500,083
+35.9%
0.00%
Q1 2022$1,370,000
+207.2%
1,104,115
+382.8%
0.00%
Q4 2021$446,000
-32.1%
228,694
-4.6%
0.00%
Q3 2021$657,000
+1628.9%
239,730
+1905.3%
0.00%
Q2 2021$38,000
-83.5%
11,955
-89.0%
0.00%
Q1 2021$230,000
+995.2%
108,200
+612.5%
0.00%
Q2 2018$21,0000.0%15,187
+13.4%
0.00%
Q3 2017$21,00013,3900.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders